Deficiency of Sphingosine-1-Phosphate Receptor 2 (S1P₂) Attenuates Bleomycin-Induced Pulmonary Fibrosis
10.4062/biomolther.2018.131
- Author:
Soo Jin PARK
1
;
Dong Soon IM
Author Information
1. College of Pharmacy, Pusan National University, Busan 46241, Republic of Korea. imds@pusan.ac.kr
- Publication Type:Original Article
- Keywords:
Fibrosis;
Inflammation;
Lung;
Sphingosine 1-phosphate;
S1P₂
- MeSH:
Animals;
Bleomycin;
Bronchoalveolar Lavage;
Epithelial Cells;
Epithelial-Mesenchymal Transition;
Extracellular Matrix;
Fibrosis;
Humans;
Idiopathic Pulmonary Fibrosis;
Inflammation;
Lung;
Mice;
Phosphotransferases;
Pneumonia;
Pulmonary Fibrosis;
Receptors, Lysosphingolipid;
Sphingosine
- From:Biomolecules & Therapeutics
2019;27(3):318-326
- CountryRepublic of Korea
- Language:English
-
Abstract:
Sphingosine 1-phosphate (S1P) levels are often found to be elevated in serum, bronchoalveolar lavage, and lung tissue of idiopathic pulmonary fibrosis patients and experimental mouse models. Although the roles of sphingosine kinase 1 and S1P receptors have been implicated in fibrosis, the underlying mechanism of fibrosis via Sphingosine 1-phosphate receptor 2 (S1P₂) has not been fully investigated. Therefore, in this study, the roles of S1P₂ in lung inflammation and fibrosis was investigated by means of a bleomycin-induced lung fibrosis model and lung epithelial cells. Bleomycin was found to induce lung inflammation on day 7 and fibrosis on day 28 of treatment. On the 7(th) day after bleomycin administration, S1P₂ deficient mice exhibited significantly less pulmonary inflammation, including cell infiltration and pro-inflammatory cytokine induction, than the wild type mice. On the 28(th) day after bleomycin treatment, severe inflammation and fibrosis were observed in lung tissues from wild type mice, while lung tissues from S1P₂ deficient mice showed less inflammation and fibrosis. Increase in TGF-β1-induced extracellular matrix accumulation and epithelial-mesenchymal transition were inhibited by JTE-013, a S1P₂ antagonist, in A549 lung epithelial cells. Taken together, pro-inflammatory and pro-fibrotic functions of S1P₂ were elucidated using a bleomycin-induced fibrosis model. Notably, S1P₂ was found to mediate epithelial-mesenchymal transition in fibrotic responses. Therefore, the results of this study indicate that S1P₂ could be a promising therapeutic target for the treatment of pulmonary fibrosis.
